PODD Stock: Price, Earnings History and SEC Filings
Insulet Corporation (PODD) last traded at $149.68, down 1.85% on the latest session and up 14.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.66 against an analyst estimate of $1.44, a beat of 15.3%.
$149.68 -1.85%
1 month+14.72%
52-week high$354.88
52-week low$126.40
Volume1.09M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PODD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $1.66 | $1.44 | +15.28% |
| Mar 2026 | May 6, 2026 | $1.42 | $1.14 | +24.56% |
| Dec 2025 | Feb 18, 2026 | $1.55 | $1.48 | +4.73% |
| Sep 2025 | Nov 6, 2025 | $1.24 | $1.13 | +9.73% |
PODD beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PODD
SEC filing data is not available right now. You can search for PODD on SEC EDGAR.
PODD news
- Insulet (PODD) Reports Next Week: Wall Street Expects Earnings GrowthOct 28, 2026 · finance.yahoo.com
- Insulet's Quarterly Earnings Preview: What You Need to KnowOct 27, 2026 · barchart.com
- Insulet (PODD) Could Be 11% Undervalued On Omnipod Discover LaunchOct 26, 2026 · finance.yahoo.com
- DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT StudyOct 20, 2026 · finance.yahoo.com
- 2 Profitable Stocks to Keep an Eye On and 1 We QuestionOct 19, 2026 · finance.yahoo.com
About Insulet Corporation
Insulet Corporation (PODD) is a US-listed public company on Nasdaq.